Charcot-Marie-Tooth disease type 2G (Q104267): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A doença de Charcot-Marie-Tooth autossômica dominante tipo 2G (CMT2G) é uma forma de doença de Charcot-Marie-Tooth axonal, uma neuropatia periférica sensitivomotora. A CMT2G [foi descrita apenas em uma família e] tem início associado a desenvolvimento de deformidades nos pés e dificuldades de deambulação entre a 1ª e a 8ª décadas, com intervalo mediano na 2ª. Fraqueza e perda sensitva envolvem primariamente as pernas e os reflexos tendinosos dos tornozelos estão reduzidos. CMT2G tem um curso lentamente progressivo.
description / endescription / en
 
Autosomal dominant Charcot-Marie-Tooth disease type 2G (CMT2G) is a form of axonal Charcot-Marie-Tooth disease, a peripheral sensorimotor neuropathy. CMT2G [has only been described in 1 family and] onset is associated to development of foot deformity and walking difficulties between the 1st and the 8th decades, with a median range in the 2nd one. Weakness and sensory loss involve primarily the legs and ankles tendon reflexes are reduced. CMT2G has a slowly progressive course.

Revision as of 10:07, 17 August 2026

Autosomal dominant Charcot-Marie-Tooth disease type 2G (CMT2G) is a form of axonal Charcot-Marie-Tooth disease, a peripheral sensorimotor neuropathy. CMT2G [has only been described in 1 family and] onset is associated to development of foot deformity and walking difficulties between the 1st and the 8th decades, with a median range in the 2nd one. Weakness and sensory loss involve primarily the legs and ankles tendon reflexes are reduced. CMT2G has a slowly progressive course.
Language Label Description Also known as
default for all languages
ID_1279608482
    English
    Charcot-Marie-Tooth disease type 2G
    Autosomal dominant Charcot-Marie-Tooth disease type 2G (CMT2G) is a form of axonal Charcot-Marie-Tooth disease, a peripheral sensorimotor neuropathy. CMT2G [has only been described in 1 family and] onset is associated to development of foot deformity and walking difficulties between the 1st and the 8th decades, with a median range in the 2nd one. Weakness and sensory loss involve primarily the legs and ankles tendon reflexes are reduced. CMT2G has a slowly progressive course.

      Statements